TRANSCENTA

Biochemical medicines for the treatment of cancer, musculoskeletal, genitourinary, oncological, ophthalmic, gastrointestinal, and immune system related diseases and disorders; Dietary supplements in the form of liquid; Pharmaceutical preparations for the treatment of cancer, musculoskeletal, genitourinary, oncological, ophthalmic, gastrointestinal, and immune system related diseases and disorders; Biological preparations for medical purposes for the treatment of cancer, musculoskeletal, genitourinary, oncological, ophthalmic, gastrointestinal, and immune system related diseases and disorders; Drugs for medical purposes for the treatment of cancer, musculoskeletal, genitourinary, oncological, ophthalmic, gastrointestinal, and immune system related diseases and disorders; Injectable pharmaceuticals for the treatment of cancer, musculoskeletal, genitourinary, oncological, ophthalmic, gastrointestinal, and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of cancer, musculoskeletal, genitourinary, oncological, ophthalmic, gastrointestinal, and immune system related diseases and disorders; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer